Histopathological and immunohistochemical studies on the adrenal cortical tumors of Egyptian patients

Life Science Journal

Volumn 8, Issue 4, 2011, Pages 970-978

  Samia, M Sanad ^a   Mahmoud, A El Baz ^b   Omar, I Ghonemy ^c   Hassan, ^c   Abo El Nazar, F ^d  

^a Zagazig University   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

^c BENHA UNIVERSITY   (Egypt)

^d MANSOURA UNIVERSITY   (Egypt)

Author keywords

Adrenal cortical tumors; Cytokeratin; Histopathology; Immunohistochemistry; Vimentin

Indexed keywords

EID: 84860501730     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. ANGUS, B., KIBERU, S. and PURVIS, J. (1988): Cytokeratins in cervical dysplasia: a comparative study immuno-histochemical staining using monoclonal antibodies NCL-5D3, CAM5.2, and PLL1. J. Pathol., 155:71-75.
2. BARZON, L., MASI, G., FINCATI, K., PACENTI, M., FALLO, F. and PALU, G. (2005): Shift from conn's syndrome to cushing's syndrome in a recurrent adrenocortical carcinoma. Eur. J. Endocrinol., 5: 629-636.
3. CARD, R., BRODEUR, G.M., AZAR, C. and BROTHER, M. (1992): Neuroblastoma. Effect of genetic factors on the prognosis and treatment., 70: 1685-1694.
4. CONN, J.W., KNOPF, R.F. and NESBIT, R.M. (1964): Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am. J. Surg., 107: 159-172.
5. Cote, J., Cordon-Cardo, C., Reuter, V.E. and Rosen, P.P. (1990): Immuno-pathology of adrenal and renal cortical tumors. Coordinated change in antigenexpression is associated with neoplastic conversion in the adrenal cortex. Am. J. Pathol., 136: 1077-1084.
6. DIMAN, V., HUGLO, D., NOCAUDIE, M., PATTOU, F., PROYE, C. and WEMEAU, J.L. (1992): Chromogranin A assay and (13) I-MIBG scintigraphy for diagnosis and-follow-up of pheochromocytoma. J. Nud. Med., 42 (7): 993-997.
7. ELIAS, J.M., MARGIOTTA, M. and GABROC, D. (1989): Sensitivity and detection efficiency of the peroxidase anti peroxidase (PAP), avidin-biotin complex (ABC) and peroxidase-labeled avidin-biotin (LAB) methods. Am. J. Pathol., 92: 62-71.
8. Evans, H.L., D'Angio, G.J., Sather, H.N. and Vassilopoulou-Sellin, R. (1996): Adrenal cortical neoplasms. A study of 56 cases. Am. J. Clin. Pathol., 1:76-86.
9. GAFFEY, M.J., TRAWEEK, S.T. and MILLS, S.E. (1992): Cytokeratin experssion in adrenal cortical neoplasia: an immunohistochemical and biochemical study with implications for the differential diagnosis of adrenocortical, hepatocellular, and renal cell carcinoma. Hum. Pathol., 23:144-153.
10. GORDON, H. and SWEETS, H.H. (1936): A sampling method for the silver impregnation of reticulum. Ameerican Journal of Pathology, 12: 545-552.
11. HAAK, H.R., FLEUREN, G.J., HERMANS, J., COBBEN, L. and FLEUREN, G.L. (1995): Neuroendocrine differentiation of adrenocortical tumors. Cancer., 75: 860-864.
12. HANDLER, J. (2003): Case studies in hypertension. Adrenal carcinoma. J.Clin. Hypertens (Greenwich), 5: 355-358.
13. HARRIS, H.F. (1900): On the rapid conversion of haematoxylin into haematin in staining reaction. J.Appl. Microsc. Lab. Meth., 3: 77.
14. HENLEY, D.J., VAN HEERDEN, J.A., GRANT, C.S., CARNEY, J.A. and CARPENTER, P.C. (1983): Adrenal Cortical Carcinoma - a continuing Challenge. Surger., 94: 926-931.
15. HOANG, M.P., AYALA, A.G. and ALBORESSAAVEDRA, J. (2002): Oncocytic adrenocortical carcinoma: a morphologic, immunohisto-chemical and ultrastructural study of four cases. Mod. Pathol., 9:973-978.
16. HOTCHKISS, R.D. (1948): A microchemical reaction resulting in the staining of polysaccharide structures in fixed tissue preparation. Arch. Biochem., 16:131-141.
17. HSU, S.M., RAINE, L. and FANGER, H. (1981): A comparative study of the peroxidaseantiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am. J. Clin. Pathol., 75:734-738.
18. LACK, E.E., KOZAKWICH, H.P. and OERLEL, J.E. (1997): Embryology, developmental anatomy, and selected aspects of non-neoplastic pathology In: Lack, E.E., ed. Pathology of the adrenal glands. Lack, E.E. edition. New York: Churchill Livingstone, 1-74.
19. LACK, E.E., PAGE, D.L. and WEISS, L.M. (1990): Recommendations for Reporting of tumors of the adrenal cortex and medulla. Hum. Pathol., 30: 887-890.
20. LACK, E.E., TRAVIS, W.D. and OERLEL, J.E. (1999):Adrenal cortical meoplasms. In Lack, E.E. (ed.) pathology of the adrenal glands. Churchill Livingstone, New York, P.115-171.
21. LEWINSKY, B.S., GRIGOR, K.M., SYMINGTON, T. and NEVILLE, A.M. (1974): The clinical and pathologic features of non-hormonal adrenocortical tumors. Report of 20 new cases and review of the literature. Cancer., 33: 778-790.
22. NAKANO, M. (1988): Adrenal Cortical Corcinoma. A clinicopathological and immunohistochemical study of 91 autopsy cases. Acta. Pathol., 38: 163-80.
23. NEVILLE, A.M., SYMINGTON, T. and O'HERE, M.J. (1985): In the human adrenal cortex. Patholgy and Biology. An integrated Approch. New York, Spinger-verlage.
24. RAIKHLIN, N.T., BARONIN, A.A., SMIRNOVA, E.A. and PETROV, S.V. (2002): Immunohistochemical identification of hormonallyinactive tumors of adrenal gland. Vopr. Onkol., 6: 684-690.
25. SAEGER, W. (2000): Histpathological classification of adrenal tumors. Eur. J. Clin. Invest., 3: 58-62.
26. SAEGER, W., FASSNACHT, M., CHITA, R., PRAGER, G., NIES, C. LORENS, K., SIMON, D. and REINCKE, M. (2003): High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. Hum. Pathol., 34: 180-186.
27. SCHEINGAR, D.E., DOHERTY, G.M., GAUGER, P.G., GIORDANO, I.J., HAMMER, G.D., KOROBKIN, M. and WORDEN, F.P. (2005): Management of patients with adrenal cancer: recommendations of an international consensues conference. Endocr.Retat.Cancer.,12: 667-680.
28. SONG, S.Y., PARKS, E.R., KIM, S.R. and SUH, Y.I. (2004): Oncocytic adrenocortical carcinomas: A pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol. Int., 8: 603-610.
29. TATIC, S., HAVELKA, M., PAUNOVIC, I., BOTIC, V., DIKLIC, A., BRASANAC, D. and JANKOVIC, R. (2002): Pheochromocytomapathohistologic and immunohisto-chemical aspects. Srp. Arch. Celok. Lek., 2: 7-13.
30. TISSIER, F., CAVARD, C., GROUSSIN, L., PERLEMOIN, K., FUMEY, G., HOGNERE, A.M., RENECORAIL, F., JULLIAN, E., GICQUEL, C. and BERAGANA, X. (2005): Mutations of betacatenin in adenocortical tumors: Activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumor cancer Res., (17): 7622-7627.
31. WEISS, L.M., MEDEIROS, L.J. and VICKERY, A.L. (1989): Pathologic feature of prognostic significance in adrenal cortical carcinoma. Am. J. Surg. Pathol., 13: 202-206.
32. WIENEKE, J.A., THOMPSON, L.D. and HEFFESS, C.S. (2003): Adrenal cortical neoplasms in the pediatric population: A clinicopathologic and immunophenotypic analysis of 83 patients. Am. J. Surg. Pathol., 7: 867-881.
33. WOOTEN, M.D. and KING, D.K. (1993): Adrenal cortical carcinpoma. Epidemiology and treatment with mitotane and areview of literature. Cancer, 72: 3145-3155.